Longitudinal Assessment of Arthralgia and Related Symptoms in Breast Cancer Patients Receiving Aromatase Inhibitors.

Trial Profile

Longitudinal Assessment of Arthralgia and Related Symptoms in Breast Cancer Patients Receiving Aromatase Inhibitors.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 07 Feb 2017

At a glance

  • Drugs Anastrozole (Primary)
  • Indications Early breast cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 02 Feb 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2018.
    • 01 Feb 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Jun 2017, as reported by ClinicalTrials.gov.
    • 27 Jan 2015 Planned primary completion date changed from 1 Jun 2015 to 1 Jun 2016 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top